Cite
MLA Citation
Angharad G Davis et al.. “A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial.” Clinical infectious diseases, vol. 76, 2023, pp. 1412–1422. http://access.bl.uk/ark:/81055/vdc_100184059776.0x00001d